Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
285 Leser
Artikel bewerten:
(3)

Stock Market Press Focuses on Pets and CBD With News of Metatron, Inc. Expanding Their Reach To Pet CBD; Other Companies Discussed Include Aurora Cannabis Inc. and Canopy Growth Corporation

NEW YORK, NY / ACCESSWIRE / March 13, 2019 / Stock Market Press (SMP) focuses on the rapidly growing Pet CBD market. Companies covered in this spotlight include Aurora Cannabis Inc. (NYSE: ACB), Canopy Growth Corporation (TSX: WEED), (NYSE: CGC) and Metatron, Inc. (OTC PINK: MRNJ).

With the recent passage and enactment of the 2018 Farm Bill, the USA federal regulations on Hemp have been lifted, opening up the doors to a hemp boom. Superior quality, along with increased production, are seeing prices drop and more companies expanding their CBD products to include the pet market. In the USA alone, the general pet market is expected to have topped $72B for 2018, an increase of almost 4% from 2017's $69.5B. With the advent of increased Pet CBD products, 2019 could see a much larger increase. Enter PetMojo and Metatron, Inc. (OTC PINK: MRNJ).

Metatron, Inc. (OTC PINK: MRNJ) just announced they have secured a deal with PetMojo, a company with over 20 years experience in eCommerce and 15 years experience running luxury pet services businesses. Through their combined talents, PetMojo and Metatron, Inc. (OTC PINK: MRNJ) are going to develop and market a new Pet CBD product sales App for both iTunes and Google Play users.

'Pet-and-animal product CBD sales are estimated to reach $125 million by 2022, representing a 5-year CAGR of 57 percent, among the fastest-growing sectors in the CBD market.' - Metatron, Inc. Press Release.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has received approval to being researching the effectiveness of cannabidiol ('CBD') to treat anxiety in certain animals. Marc Wayne, Managing Director, Canopy Health Innovations commented, 'The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians.'

The CBD market growth is worldwide, even a country like Germany is seeing its market opening up. Companies like Aurora Cannabis Inc. (NYSE: ACB) can now expand sales of cannabis oil to German pharmacies after receiving approval. They are making the difficult inroads that will allow companies like PetMojo and Metatron, Inc. (OTC PINK: MRNJ) to bring their products to the German pet owning population, a group who cares for over 34M pets.

Metatron, Inc. (OTC PINK: MRNJ) is tapping into another huge market, increasing both their product exposure as well as revenues, since the majority of CBD pet products are sold online.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005
info@stockmarketpress.com
https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be 'forward-looking statements.' Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/

SOURCE: Stock Market Press



View source version on accesswire.com:
https://www.accesswire.com/538789/Stock-Market-Press-Focuses-on-Pets-and-CBD-With-News-of-Metatron-Inc-Expanding-Their-Reach-To-Pet-CBD-Other-Companies-Discussed-Include-Aurora-Cannabis-Inc-and-Canopy-Growth-Corporation

© 2019 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.